U.S. Archives – Page 3 of 8 – Treatment Action Group

Joint Statement from Leading HIV/AIDS and Viral Hepatitis Advocates regarding Manufacturer Action on the 340B Drug Pricing Program

April 20, 2022
Dorrit Walsh

A group of six leading HIV/AIDS and viral hepatitis advocates today released the following joint statement regarding recent manufacturer action against the 340B Drug Pricing Program:

Terraforming the Policy Landscape to Enable Access to Long-Acting Technologies

October 6, 2021
Dorrit Walsh

By Annette Gaudino and Suraj Madoori Let’s Define Terraforming Terraforming — or “earth-shaping” — the transformation of an alien planet into one where humans can live, is probably most familiar to science-fiction fans and Minecraft players. Terraforming is more intensive…

Does Delta Mean Change? Community Update on the Delta Variant

August 31, 2021
Dorrit Walsh

On August 31, 2021, Treatment Action Group (TAG) and Black AIDS Institute (BAI) held a community discussion to get the latest updates on the impact of the Delta variant.

Comments to NIH Leadership Regarding the Proposed Advanced Research Projects Agency for Health

August 5, 2021
Dorrit Walsh

In response to the Biden administration's intention to create a new research agency under the NIH called the Advanced Research Projects Agency for Health (ARPA-H), TAG and AVAC were invited to present remarks and guidance on the behalf of the Federal AIDS Policy Partnership and Research Work Group (RWG).

TAG Testimonies on Funding Priorities FY22 to Senate LHHS and Related Agencies

July 9, 2021
Dorrit Walsh

On June 24, TAG submitted testimony to the Senate Subcommittee on Labor, Health and Human Services, Education, and Related Agencies outlining funding priorities for fiscal year 2022.

TAG Urges Governor to Sign New York State Bill Expanding Adult Vaccines Available in Pharmacies

June 3, 2021
Dorrit Walsh

The bill, S4807A (Stavisky) / A6476A (Hyndman), improves preventive viral hepatitis vaccine access, and is particularly important for people who use drugs and unhoused New Yorkers.

TAG Comments on NIST’s Proposed Rulemaking Changes

April 4, 2021
Dorrit Walsh

TAG submitted comments in response to the National Institute of Standards and Technology's (NIST) proposed change to rulemaking, strongly opposing amendments to remove crucial public health safeguards from the Bayh-Dole Act. March-in rights and other provisions to hold manufacturers accountable when federally funded inventions are exorbitantly priced and are critically important to public health and the right to science.

TAG Applauds Dr. Demetre Daskalakis’ Appointment as CDC Director of the Division of HIV/AIDS Prevention: NYC’s Loss is America’s Gain

November 19, 2020
Dorrit Walsh

Treatment Action Group applauds the appointment of Dr. Demetre Daskalakis to helm the U.S. Centers for Disease Control and Prevention (CDC)’s Division of HIV/AIDS Prevention (DHAP). We can think of no better public health practitioner to embody true innovation and disrupt the status quo in our national HIV prevention response.

Efficacy News from Second COVID-19 Vaccine Trial Underscores Need for Transparency and Cooperation Between Outgoing and Incoming US Administrations

November 16, 2020
Dorrit Walsh

AVAC and Treatment Action Group (TAG) welcome today’s announcement that preliminary data from the efficacy trial of Moderna’s mRNA COVID-19 vaccine indicate high-level of protection against COVID-19.

TAG Welcomes the Election of Joseph R. Biden Jr. and Kamala D. Harris

November 9, 2020
Dorrit Walsh

Treatment Action Group (TAG) congratulates President-elect Joe Biden and Vice President-elect Kamala Harris on their ascension to the highest offices of the United States. Their victory in both the popular and electoral vote is historic.